The “Monthly Roundup” is a monthly newsletter dedicated to sharing the latest news from the Duke Global Health Innovation Center and Innovations in Healthcare. View the December 2024 newsletter. Subscribe to the monthly newsletter.
This newsletter aims to provide a central hub for information, milestones, and updates regarding the COVID Treatment QuickStart Consortium. The COVID Treatment QuickStart Consortium partners with governments to rapidly introduce and scale access to COVID-19 oral antiviral therapies in vulnerable and high-risk populations presenting with mild to moderate symptoms within five days of symptom onset through a public health test-and-treat model. QuickStart’s top priorities are: Ensuring treatments are accessible in all parts of the world; Preparing for potential future COVID-19 surges; and Building primary healthcare capacity for test-and-treat beyond COVID-19. View the December 2024 QuickStart newsletter. Subscribe to the QuickStart newsletter.
“Trust Matters” is a monthly newsletter dedicated to exploring the critical role that trust plays in achieving health outcomes globally, regionally, and nationally. This newsletter aims to provide a central hub for information about the diverse range of initiatives and developments in the realm of trust. This work is led by the Duke Global Health Innovation Center, the Duke-Margolis Institute for Health Policy, and the Duke Global Health Institute, at Duke University. View the December 2024 Trust Matters newsletter. Subscribe to the Trust Matters newsletter and/or contribute your work on trust in health to this newsletter.
Welcome to the fourth issue of our biweekly report, “Mpox: Transparency and Accountability for the Global Response.” In this edition, we provide a comprehensive update on the latest developments and insights across all topic areas, featuring our most recent analyses and findings since the last issue. This report will be updated and shared every other week with our community. As always, we aim to serve as an external, independent source for tracking and catalyzing effective actions to meet and increase commitments, and to hold the key stakeholders to account for achieving emergency preparedness and response goals. Access the full report.
QuickStart representatives presented the "Rapid introduction of oral antivirals for COVID-19: implementation of a test and treat program in four African countries" poster at the 20th International Congress on Infectious Diseases (ICID) from 3-6 December 2024. [caption id="attachment_6004" align="alignright" width="1808"] International Conference on Infectious Disease 2024 poster presentation[/caption]
Welcome to the third issue of our biweekly report, “Mpox: Transparency and Accountability for the Global Response.” In this edition, we provide a comprehensive update on the latest developments and insights across all topic areas, featuring our most recent analyses and findings since the last issue. This report will be updated and shared every other week with our community. As always, we aim to serve as an external, independent source for tracking and catalyzing effective actions to meet and increase commitments, and to hold the key stakeholders to account for achieving emergency preparedness and response goals. Access the full report.
“Trust Matters” is a monthly newsletter dedicated to exploring the critical role that trust plays in achieving health outcomes globally, regionally, and nationally. This newsletter aims to provide a central hub for information about the diverse range of initiatives and developments in the realm of trust. This work is led by the Duke Global Health Innovation Center, the Duke-Margolis Institute for Health Policy, and the Duke Global Health Institute, at Duke University. View the November 2024 Trust Matters newsletter. Subscribe to the Trust Matters newsletter and/or contribute your work on trust in health to this newsletter.
The “Monthly Roundup” is a monthly newsletter dedicated to sharing the latest news from the Duke Global Health Innovation Center and Innovations in Healthcare. View the November 2024 newsletter. Subscribe to the monthly newsletter.
Welcome to the second issue of our biweekly report, "Tracking and Analyzing Medical Countermeasures for Emerging Health Challenges: Mpox." In this edition, we provide a comprehensive update on the latest developments and insights across all topic areas, featuring our most recent analyses and findings since the last issue. This report will be updated and shared every other week with our community. As always, we aim to serve as an external, independent source for tracking and catalyzing effective actions to meet and increase commitments, and to hold the key stakeholders to account for achieving emergency preparedness and response goals. Access the full report.
Welcome to the final installment of the Innovations in Healthcare Global Health Innovation Grantees blog series. History of the Global Health Innovation Grants Program Since 2016, The Pfizer Foundation’s Global Health Innovation Grants (GHIG) program has supported community-based initiatives that aim to improve quality of care and strengthen health systems in lower income countries. Innovations in Healthcare supports GHIG grantees by facilitating connections in the ecosystem, hosting GHIG-specific workshops and peer convenings at the Annual Forum, and conducting regular program monitoring to provide portfolio and individual results to the Pfizer Foundation. Now in its eighth year (GHIG8), 20 new recipients of the one-year grant program have each received $100,000 USD to drive innovative solutions that help address vaccine-preventable illness in their communities. [caption id="attachment_5800" align="aligncenter" width="596"] GHIG8 geographic scope. This year’s grantees address a…
